ATE333501T1 - Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps) - Google Patents
Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps)Info
- Publication number
- ATE333501T1 ATE333501T1 AT98942011T AT98942011T ATE333501T1 AT E333501 T1 ATE333501 T1 AT E333501T1 AT 98942011 T AT98942011 T AT 98942011T AT 98942011 T AT98942011 T AT 98942011T AT E333501 T1 ATE333501 T1 AT E333501T1
- Authority
- AT
- Austria
- Prior art keywords
- vlps
- particles
- reassembly
- papillomavirus virus
- papillomavirus
- Prior art date
Links
- 241001631646 Papillomaviridae Species 0.000 title abstract 5
- 239000002245 particle Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/802—Virus-based particle
- Y10S977/803—Containing biological material in its interior
- Y10S977/804—Containing nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92399797A | 1997-09-05 | 1997-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE333501T1 true ATE333501T1 (de) | 2006-08-15 |
Family
ID=25449564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98942011T ATE333501T1 (de) | 1997-09-05 | 1998-08-19 | Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps) |
Country Status (16)
Country | Link |
---|---|
US (2) | US6416945B1 (de) |
EP (2) | EP1015561B1 (de) |
JP (2) | JP4199416B2 (de) |
AT (1) | ATE333501T1 (de) |
AU (1) | AU742409B2 (de) |
CA (1) | CA2302545C (de) |
CY (2) | CY1107987T1 (de) |
DE (3) | DE69835294T2 (de) |
DK (1) | DK1015561T3 (de) |
ES (2) | ES2572628T3 (de) |
FR (1) | FR07C0012I2 (de) |
HK (1) | HK1030797A1 (de) |
LU (1) | LU91314I2 (de) |
NL (1) | NL300264I2 (de) |
PT (1) | PT1015561E (de) |
WO (1) | WO1999013056A1 (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8062642B1 (en) | 1993-03-09 | 2011-11-22 | University Of Rochester | Production of papillomavirus capsid protein and virus-like particles |
CA2257822A1 (en) * | 1996-07-17 | 1998-01-22 | The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services | Infectious papillomavirus pseudoviral particles |
US6962777B1 (en) * | 1997-09-05 | 2005-11-08 | Medimmune, Inc. | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents |
US7351533B2 (en) * | 1997-09-05 | 2008-04-01 | Medimmune, Inc. | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
CU22871A1 (es) | 1998-12-02 | 2003-10-21 | Ct Ingenieria Genetica Biotech | Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal |
US6436402B1 (en) * | 1999-10-15 | 2002-08-20 | Merck & Co., Inc. | Process for making human papillomavirus virus-like particles with improved properties |
ES2325053T3 (es) * | 1999-12-09 | 2009-08-25 | Medimmune, Llc | Metodo in vitro para desensamblaje/reensamblaje de particulas similares a virus de papilomavirus (vlp). |
EP1305039B1 (de) * | 2000-07-06 | 2008-12-31 | Georgetown University | Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen |
JP4746819B2 (ja) * | 2000-09-18 | 2011-08-10 | メディミューン,エルエルシー | ワクチンの免疫原性を測定する試験管内検定 |
CN1114690C (zh) * | 2001-05-15 | 2003-07-16 | 乔良 | 乳头瘤假病毒及其制备方法 |
US20040121465A1 (en) * | 2002-02-14 | 2004-06-24 | Novavax, Inc. | Optimization of gene sequences of virus-like particles for expression in insect cells |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
DE10224111A1 (de) * | 2002-05-29 | 2003-12-18 | November Ag Molekulare Medizin | Verfahren zum Assemblieren von Untereinheiten zu Kapsoiden |
JP2006507800A (ja) | 2002-06-07 | 2006-03-09 | ラージ・スケール・バイオロジー・コーポレイション | 可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム |
EA200701633A1 (ru) | 2002-12-20 | 2007-12-28 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1 |
US20080131928A1 (en) | 2004-07-01 | 2008-06-05 | Hiroshi Handa | Viral Particle-Like Construct and Method of Forming the Same Under Physiological Conditions |
CN101287489A (zh) * | 2005-06-01 | 2008-10-15 | 陶氏环球技术公司 | 多价病毒样颗粒的生产 |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
SG179488A1 (en) | 2007-03-14 | 2012-04-27 | Ligocyte Pharmaceuticals Inc | Virus like particle purification |
AU2008279584A1 (en) * | 2007-04-27 | 2009-01-29 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
US8394411B2 (en) | 2007-05-08 | 2013-03-12 | The United States of America as represented by the Secretary, Dept. of Health and Human Services National Institutes of Health | Papillomavirus pseudoviruses for detection and therapy of tumors |
GB0820822D0 (en) | 2008-11-13 | 2008-12-24 | Inst Catala D Oncologia | Novel product and processes |
US8663951B2 (en) * | 2009-01-09 | 2014-03-04 | Academia Sinica | Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system |
ES2683352T3 (es) | 2009-04-13 | 2018-09-26 | Inserm - Institut National De La Santé Et De La Recherche Médicale | Partículas de HPV y usos de las mismas |
CA2768172A1 (en) | 2009-06-25 | 2010-12-29 | Glaxosmithkline Biologicals S.A. | Novel compositions |
WO2011000058A1 (en) * | 2009-07-03 | 2011-01-06 | The University Of Queensland | A method of preparation of a biological particulate structure |
WO2011039646A2 (en) | 2009-09-30 | 2011-04-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Papilloma virus -like particles for targeted gene delivery |
US20130115247A1 (en) * | 2011-11-05 | 2013-05-09 | Aura Biosciences, Inc. | Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy |
US20130116408A1 (en) * | 2011-11-05 | 2013-05-09 | Aura Biosciences, Inc. | Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy |
WO2013119877A1 (en) | 2012-02-07 | 2013-08-15 | Aura Biosciences, Inc. | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
WO2013139744A1 (en) | 2012-03-18 | 2013-09-26 | Glaxosmithkline Biologicals S.A. | Method of vaccination against human papillomavirus |
JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
KR101559622B1 (ko) | 2012-07-30 | 2015-10-13 | 중앙대학교 산학협력단 | 인유두종바이러스 바이러스 유사입자의 고효율 정제방법 |
DK3046583T3 (da) | 2013-09-18 | 2019-05-20 | Aura Biosciences Inc | Viruslignende partikelkonjugater til behandling af tumorer |
EP3191505A2 (de) * | 2014-09-11 | 2017-07-19 | Cadila Healthcare Limited | Überlegene antigenen des menschlichen papillomvirus mit überlegenen immunologischen eigenschaften und impfstoff damit |
RU2677336C2 (ru) * | 2014-12-26 | 2019-01-16 | Айджин, Инк. | Способ получения вирусоподобных частиц папилломавируса человека |
JP2018536434A (ja) | 2015-10-30 | 2018-12-13 | アレタ・バイオセラピューティクス・インコーポレイテッドAleta Biotherapeutics Inc. | 腫瘍形質導入のための組成物及び方法 |
EP3368559A4 (de) | 2015-10-30 | 2020-01-15 | Aleta Biotherapeutics Inc. | Zusammensetzungen und verfahren zur behandlung von krebs |
JP2018532801A (ja) | 2015-10-30 | 2018-11-08 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 標的化がん療法 |
GB201708709D0 (en) * | 2017-06-01 | 2017-07-19 | Univ York | Virus like particle |
KR20200084883A (ko) | 2017-11-06 | 2020-07-13 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 기존의 미생물 면역을 활용한 암 치료 |
JP2021502822A (ja) | 2017-11-14 | 2021-02-04 | フラウンホファー ゲセルシャフト ツール フェールデルンク ダー アンゲヴァンテン フォルシュンク エー.ファオ. | in vitro及びin vivoでの遺伝子送達のための非ヒトパピローマウイルス |
GB202011609D0 (en) | 2020-07-27 | 2020-09-09 | Univ Leeds Innovations Ltd | Coronaviral packaging signals |
WO2024111566A1 (ja) * | 2022-11-22 | 2024-05-30 | 一般財団法人阪大微生物病研究会 | 安定化されたvlpワクチン |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992016638A1 (en) * | 1991-03-14 | 1992-10-01 | 5 Prime --> 3 Prime, Inc. | Transduction vehicles for transferring dna to a mammalian cell |
FR2768749A1 (fr) * | 1997-09-22 | 1999-03-26 | Inst Nat Sante Rech Med | Virus artificiels derives de papillomavirus, et leurs utilisations, notamment en therapie genique |
-
1998
- 1998-08-19 AU AU90154/98A patent/AU742409B2/en not_active Expired
- 1998-08-19 ES ES06075489.2T patent/ES2572628T3/es not_active Expired - Lifetime
- 1998-08-19 DE DE69835294T patent/DE69835294T2/de not_active Expired - Lifetime
- 1998-08-19 AT AT98942011T patent/ATE333501T1/de active
- 1998-08-19 WO PCT/US1998/016464 patent/WO1999013056A1/en active IP Right Grant
- 1998-08-19 PT PT98942011T patent/PT1015561E/pt unknown
- 1998-08-19 ES ES98942011T patent/ES2268787T3/es not_active Expired - Lifetime
- 1998-08-19 JP JP2000510845A patent/JP4199416B2/ja not_active Expired - Lifetime
- 1998-08-19 DE DE200712000015 patent/DE122007000015I2/de active Active
- 1998-08-19 DE DE1998635294 patent/DE122007000015I1/de active Pending
- 1998-08-19 CA CA2302545A patent/CA2302545C/en not_active Expired - Lifetime
- 1998-08-19 EP EP98942011A patent/EP1015561B1/de not_active Expired - Lifetime
- 1998-08-19 DK DK98942011T patent/DK1015561T3/da active
- 1998-08-19 EP EP06075489.2A patent/EP1700911B1/de not_active Expired - Lifetime
-
1999
- 1999-08-24 US US09/379,615 patent/US6416945B1/en not_active Expired - Lifetime
- 1999-08-24 US US09/379,605 patent/US6261765B1/en not_active Expired - Lifetime
-
2001
- 2001-01-04 HK HK01100076A patent/HK1030797A1/xx not_active IP Right Cessation
-
2006
- 2006-10-12 CY CY20061101462T patent/CY1107987T1/el unknown
-
2007
- 2007-02-21 FR FR07C0012C patent/FR07C0012I2/fr active Active
- 2007-02-21 LU LU91314C patent/LU91314I2/fr unknown
- 2007-02-21 NL NL300264C patent/NL300264I2/nl unknown
-
2008
- 2008-08-06 JP JP2008202695A patent/JP4486142B2/ja not_active Expired - Lifetime
-
2016
- 2016-06-13 CY CY2007007C patent/CY2007007I2/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2572628T3 (es) | 2016-06-01 |
JP4199416B2 (ja) | 2008-12-17 |
NL300264I1 (nl) | 2007-05-01 |
US6416945B1 (en) | 2002-07-09 |
DE122007000015I1 (de) | 2007-05-24 |
PT1015561E (pt) | 2006-11-30 |
JP2009057377A (ja) | 2009-03-19 |
FR07C0012I1 (de) | 2007-03-30 |
LU91314I9 (de) | 2019-01-30 |
NL300264I2 (nl) | 2008-06-02 |
DE69835294T2 (de) | 2007-07-26 |
HK1030797A1 (en) | 2001-05-18 |
CA2302545C (en) | 2012-04-03 |
CY2007007I1 (el) | 2009-11-04 |
LU91314I2 (fr) | 2007-04-23 |
EP1700911B1 (de) | 2016-04-06 |
EP1700911A1 (de) | 2006-09-13 |
DE69835294D1 (de) | 2006-08-31 |
EP1015561A1 (de) | 2000-07-05 |
WO1999013056A1 (en) | 1999-03-18 |
CY1107987T1 (el) | 2011-04-06 |
DK1015561T3 (da) | 2006-11-13 |
FR07C0012I2 (fr) | 2007-10-26 |
JP4486142B2 (ja) | 2010-06-23 |
AU9015498A (en) | 1999-03-29 |
CA2302545A1 (en) | 1999-03-18 |
DE122007000015I2 (de) | 2008-01-24 |
JP2001515922A (ja) | 2001-09-25 |
ES2268787T3 (es) | 2007-03-16 |
EP1015561B1 (de) | 2006-07-19 |
AU742409B2 (en) | 2002-01-03 |
CY2007007I2 (el) | 2016-10-05 |
US6261765B1 (en) | 2001-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE333501T1 (de) | Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps) | |
AU5998400A (en) | In vitro reconstitution of segmented negative-strand rna viruses | |
EP1394259A3 (de) | Rekombinantes infektiöses nicht-in-Segmente-geteiltes negativ-Strange-RNS-Virus | |
ATE423204T1 (de) | Herstellung und reinigung von hepatitis c virus- ähnlichen partikeln | |
AU7007491A (en) | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses | |
ATE296111T1 (de) | Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen | |
GEP20084431B (en) | Papilloma virus vaccine | |
DE69721840D1 (en) | Zuckerrohr bacilliformviruspromotor | |
ATE306252T1 (de) | Verfahren zur herstellung kristalliner partikel zur inhalation | |
ATE231729T1 (de) | Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff | |
AU2051888A (en) | Novel process for purification of hepatitis a virions | |
ATE322252T1 (de) | Verfahren zur herstellung und sammlung von kristallinen partikeln | |
HK1045149A1 (en) | Process to separate 1,3-propanediol or glycerol, or a mixture thereof from a biological mixture. | |
DK0698668T3 (da) | Fremgangsmåde til fremstilling af L-leucin | |
DK0750669T3 (da) | Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra | |
RU93019436A (ru) | Способ получения человеческого лейкоцитарного интерферона |